These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11886762)

  • 21. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Vaidya JS
    J Natl Cancer Inst; 2008 Apr; 100(8):598-9; author reply 599. PubMed ID: 18398100
    [No Abstract]   [Full Text] [Related]  

  • 22. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Kerlikowske K; Miglioretti DL; Buist DS; Walker R; Carney PA;
    J Natl Cancer Inst; 2007 Sep; 99(17):1335-9. PubMed ID: 17698950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study.
    Sala E; Warren R; McCann J; Duffy S; Luben R; Day N
    Int J Epidemiol; 2000 Aug; 29(4):629-36. PubMed ID: 10922338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menopausal hormone therapies: their effect on mammographic density and breast cancer risk.
    Santen R
    Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():12-6. PubMed ID: 16112950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Breast density: a major parameter to follow during hormone replacement therapy].
    Gairard B; Guldenfels C; Haehnel P; Mathelin C
    Gynecol Obstet Fertil; 2009; 37(7-8):657-60. PubMed ID: 19577502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
    Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of raloxifene on mammographic breast density: a review of clinical trials.
    Pearman L; Kagan R; Arsenault J; Muram D
    Menopause; 2010; 17(3):654-9. PubMed ID: 20032799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone replacement therapy and mammographic density.
    Kilicdag EB; Bagis T; Pourbagher A; Tarim E
    Int J Gynaecol Obstet; 2004 Jul; 86(1):56-8. PubMed ID: 15207680
    [No Abstract]   [Full Text] [Related]  

  • 29. Mammographic density in women on postmenopausal hormone replacement therapy.
    Leung W; Goldberg F; Zee B; Sterns E
    Surgery; 1997 Oct; 122(4):669-73; discussion 673-4. PubMed ID: 9347841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammographic density changes during different postmenopausal hormone replacement therapies.
    Sendağ F; Coşan Terek M; Ozşener S; Oztekin K; Bilgin O; Bilgen I; Memiş A
    Fertil Steril; 2001 Sep; 76(3):445-50. PubMed ID: 11532462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast density changes associated with hormone replacement therapy in postmenopausal women. Effects on the specifity and sensitivity of mamographic screening.
    Howard JM
    Eur J Gynaecol Oncol; 2006; 27(1):104; author reply 104. PubMed ID: 16550985
    [No Abstract]   [Full Text] [Related]  

  • 32. Mammographic changes in postmenopausal women undergoing hormonal replacement therapy.
    Cyrlak D; Wong CH
    AJR Am J Roentgenol; 1993 Dec; 161(6):1177-83. PubMed ID: 8249722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
    Byrne C; Ursin G; Martin CF; Peck JD; Cole EB; Zeng D; Kim E; Yaffe MD; Boyd NF; Heiss G; McTiernan A; Chlebowski RT; Lane DS; Manson JE; Wactawski-Wende J; Pisano ED
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone therapy: the next chapter. Is it time to rewrite the book on postmenopausal hormone use?
    Harv Womens Health Watch; 2011 Mar; 18(7):1-3. PubMed ID: 21526525
    [No Abstract]   [Full Text] [Related]  

  • 35. The association between mammographic breast density and bone mineral density in the study of women's health across the nation.
    Crandall CJ; Zheng Y; Karlamangla A; Sternfeld B; Habel LA; Oestreicher N; Johnston J; Cauley JA; Greendale GA
    Ann Epidemiol; 2007 Aug; 17(8):575-83. PubMed ID: 17532645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening mammography intervals among postmenopausal hormone therapy users and nonusers.
    Onega T; MacKenzie T; Weiss J; Goodrich M; Titus-Ernstoff L
    Cancer Causes Control; 2010 Jan; 21(1):147-52. PubMed ID: 19844798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does estrogen replacement therapy reduce the risk of fatal breast cancer in postmenopausal women?
    Willis DB
    Maturitas; 1997 Jun; 27(2):105-8. PubMed ID: 9255744
    [No Abstract]   [Full Text] [Related]  

  • 38. Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo.
    Freedman M; San Martin J; O'Gorman J; Eckert S; Lippman ME; Lo SC; Walls EL; Zeng J
    J Natl Cancer Inst; 2001 Jan; 93(1):51-6. PubMed ID: 11136842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and predictive value of a mammographic recommendation for short-interval follow-up.
    Yasmeen S; Romano PS; Pettinger M; Chlebowski RT; Robbins JA; Lane DS; Hendrix SL
    J Natl Cancer Inst; 2003 Mar; 95(6):429-36. PubMed ID: 12644536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-interval follow-up mammography: are we doing the right thing?
    Kerlikowske K; Smith-Bindman R; Sickles EA
    J Natl Cancer Inst; 2003 Mar; 95(6):418-9. PubMed ID: 12644528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.